Balentine LLC’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $211K | Hold |
542
| – | – | 0.01% | 158 |
|
|
2025
Q1 | $236K | Sell |
542
-35
| -6% | -$15.2K | 0.01% | 146 |
|
|
2024
Q4 | $213K | Sell |
577
-1,506
| -72% | -$556K | 0.01% | 135 |
|
|
2024
Q3 | $1.08M | Buy |
2,083
+1,506
| +261% | +$783K | 0.04% | 63 |
|
|
2024
Q2 | $313K | Sell |
577
-1,328
| -70% | -$720K | 0.01% | 98 |
|
|
2024
Q1 | $988K | Sell |
1,905
-43
| -2% | -$22.3K | 0.03% | 192 |
|
|
2023
Q4 | $918K | Sell |
1,948
-386
| -17% | -$182K | 0.03% | 183 |
|
|
2023
Q3 | $1.02M | Buy |
2,334
+158
| +7% | +$68.8K | 0.03% | 146 |
|
|
2023
Q2 | $967K | Sell |
2,176
-436
| -17% | -$194K | 0.03% | 159 |
|
|
2023
Q1 | $1.2M | Sell |
2,612
-1,176
| -31% | -$541K | 0.04% | 142 |
|
|
2022
Q4 | $1.94M | Sell |
3,788
-254
| -6% | -$130K | 0.07% | 106 |
|
|
2022
Q3 | $1.84M | Sell |
4,042
-5,097
| -56% | -$2.32M | 0.07% | 86 |
|
|
2022
Q2 | $4.41M | Buy |
9,139
+4,696
| +106% | +$2.27M | 0.16% | 46 |
|
|
2022
Q1 | $2.18M | Buy |
4,443
+3,058
| +221% | +$1.5M | 0.07% | 78 |
|
|
2021
Q4 | $642K | Buy |
1,385
+327
| +31% | +$152K | 0.02% | 138 |
|
|
2021
Q3 | $395K | Buy |
1,058
+495
| +88% | +$185K | 0.02% | 148 |
|
|
2021
Q2 | $215K | Buy |
+563
| New | +$215K | 0.01% | 160 |
|
|
2020
Q3 | – | Sell |
-122
| Closed | -$32K | – | 364 |
|
|
2020
Q2 | $32K | Sell |
122
-450
| -79% | -$118K | ﹤0.01% | 302 |
|
|
2020
Q1 | $130K | Buy |
572
+347
| +154% | +$78.9K | 0.01% | 105 |
|
|
2019
Q4 | $68K | Buy |
225
+173
| +333% | +$52.3K | ﹤0.01% | 151 |
|
|
2019
Q3 | $12K | Buy |
52
+20
| +63% | +$4.62K | ﹤0.01% | 310 |
|
|
2019
Q2 | $9K | Buy |
+32
| New | +$9K | ﹤0.01% | 327 |
|
|
2015
Q3 | – | Sell |
-268
| Closed | -$44K | – | 460 |
|
|
2015
Q2 | $44K | Hold |
268
| – | – | 0.01% | 159 |
|
|
2015
Q1 | $41K | Buy |
+268
| New | +$41K | 0.01% | 166 |
|